Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Top Founders

Top Founders artwork

$28M Series A at $100M Val: The Pest Control SaaS Nobody Saw Coming

May 27, 202621 minAudio

How do you build a $100M SaaS company by charging apartment residents $5 a month to keep rats out of their bedroom? Justin Clements is the co-founder and CEO of PestShare, an on-demand pest control platform embedded inside property management software. He bootstrapped from 2019 to 2020, raised just $5M over two rounds, then closed a $28M Series A at a $100M valuation in 2025, the same year he crossed $10M ARR. You'll learn: - Why PestShare's revenue model is structured like a warranty, and why that makes it nearly impossible to churn - The difference between contracted ARR and live ARR, and how that gap almost killed their valuation story - How embedding into the lease instead of selling direct to residents creates structural GRR that VC-backed competitors can't replicate - What it actually took to raise at 10x ARR from an investor that only backs 9 companies at a time - Why Justin's Series A investor pushed him to take $3M in personal secondary and why he says it made him take bigger swings - How IGP's PE background forced a full COGS and gross margin rebuild right after closing the round - Why "if you don't see pests it means the product isn't working" is the exact wrong way to think about pest control retention - How PestShare went from $1M (2022) to $5M (2024) to $10M (2025), doubling every year with under 1x ARR in prior capital raised - What property managers actually pay vs. what residents pay and how PestShare navigates that split without losing either side - Why Justin chose a hyper-concentrated, low-profile fund over a brand-name VC, and what they got in return Connect: YouTube: youtube.com/@NathanLatkawatch PestShare: pestshare.com Founderpath: founderpath.com

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Woah! Unicorn AI Founder Hits $50M Revenue, $3B Valuation | Parloa, Malte Kosub

    Nov 17, 202620 minVideo

    Malte Kosub, co-founder and CEO of Parloa, builds AI voice agents that answer customer service calls for enterprises like Booking.com and IKEA, and has raised $560M at a $3B valuation. Parloa reported $50M in annual...

    Credit the people on this episode

  2. How to Clone a Software Tool, Make $3m Fast

    Nov 10, 202617 minVideo

    Marc Seitz, co-founder of Papermark, built an open source DocSend alternative in a single weekend in 2023 and has bootstrapped it to $3M in ARR with 3,000 paying customers. He broke $1M in September 2025 and $2M just 4...

    Credit the people on this episode

  3. Fastest Growing AI Company Ever? CEO Reveals Revenue

    Nov 3, 202625 minAudio

    Siva Surendra, CEO of Lyzr, ended 2024 with $0 in revenue. Eighteen months later his AI agent company closed Q2 2026 at $12M ARR, is adding $1-3M of new ARR every month, runs at 95% gross margin, and is on track for...

    Credit the people on this episode

  4. $30/Night Rooms Make Him $60,000 Per Day | PadSplit CEO Atticus LeBlanc

    Oct 27, 202623 minAudio

    Atticus LeBlanc, CEO of PadSplit, rents furnished rooms for under $30 a night, has 25,000 of them filled tonight, and owns none of the real estate. PadSplit is the largest co-living marketplace in the US: 82 units at...

    Credit the people on this episode

  5. Doctor Strikes it Rich with AI Tool, $10m ARR in 6 Months | TJMLabs CEO Jonathan Adly

    Oct 20, 202623 minAudio

    Jonathan Adly spent 15 years as a licensed pharmacist before writing the first line of code for TJM Labs in November 2024 - and 18 months later he's at $25M ARR, 40% EBITDA, 450 pharmacies, and $100M raised without ever...

    Credit the people on this episode